MAPT and tauopathy: To assess in vivo effects of ALK on tau-mediated neurodegeneration, we employed a human tau transgenic fly (gl-tau2.1 line), a well-characterized tauopathy model in which human tau is expressed in the photoreceptor neurons [32].